Form 4: Vivani Medical Director Gregg Williams Granted Stock Options
SEC Form 4 Filing
Gregg Williams, a director at Vivani Medical, was granted stock options for 34,839 shares of common stock on June 27, 2024.
Summary
- Gregg Williams, a director of Vivani Medical, Inc., was granted stock options on June 27, 2024.
- The options are for 34,839 shares of Vivani Medical common stock.
- The exercise price of the options is $1.27 per share.
- The options vest on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, contingent upon continued service.
- A Limited Power of Attorney was executed on December 7, 2023, appointing Adam Mendelsohn, Judy Wong, and Brigid Makes as attorneys-in-fact to handle SEC filings.
Sentiment
Score: 7
Explanation: The document reflects a routine grant of stock options, which is generally viewed positively as it aligns director interests with shareholders. There are no indications of negative news or concerns.
Positives
- The granting of stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule incentivizes continued service and commitment to the company.
Industry Context
Stock option grants are a common practice in the pharmaceutical and biotech industries to incentivize executives and directors.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for directors in publicly traded companies, particularly in the biotech sector.
- The vesting schedule, contingent on continued service, is also a typical arrangement to ensure alignment with long-term company performance.
- Comparable companies such as Amgen, Gilead Sciences, and Biogen also utilize stock options as part of their director compensation packages.
Stakeholder Impact
- The stock option grant could potentially increase shareholder value if the director's actions lead to improved company performance.
- The grant incentivizes the director to act in the best interests of the company and its stakeholders.
Key Dates
| Date | Description |
|---|---|
| 12/07/2023 | Date of execution of the Limited Power of Attorney. |
| 06/27/2024 | Date of the stock option grant. |
| 06/26/2034 | Expiration date of the stock options. |
| 07/01/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.